Peer-Reviewed Publications

Kurve Therapeutics’ innovative technology and drug formulations have been featured in 18 peer-reviewed publications in leading medical journals with further publications pending.

We have recent and ongoing collaborations with leading research centers including Harvard, Johns Hopkins, and the Karolinska Institute.

Current Peer Review

Phase_IIB Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Peer Reviews

Phase_IIB Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease Dementia.
June 22, 2022
Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson’s disease and multiple system atrophy
April 25, 2019
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease Dementia.
June 22, 2020
Acetyl-L-Carnitine Deficiency in Patients with Major Depressive Disorder
August 21, 2018
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
November 1, 2017
Effect of intranasally administered insulin on cerebral blood flow and perfusion
March 14, 2017

Peer Reviews

Phase_IIB Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease Dementia.
June 22, 2022
Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson’s disease and multiple system atrophy
April 25, 2019
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease Dementia.
June 22, 2020
Acetyl-L-Carnitine Deficiency in Patients with Major Depressive Disorder
August 21, 2018
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
November 1, 2017
Effect of intranasally administered insulin on cerebral blood flow and perfusion
March 14, 2017

Past Clinical Trials

No data was found

Subscribe To Stay Up to Date

Stay up-to-date on Kurve Therapeutics’ breakthrough approach to treating CNS disorders by subscribing below. Learn more about CNS disorders, disease-modifying drugs and technology, clinical trials, and case studies. Kurve’s industry experts will help keep you informed.

A full list of Kurve’s active projects are available upon request.

If you have additional questions, please contact us.